In human alloreactive CD4⁺ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets
- PMID: 26935268
- DOI: 10.3892/mmr.2016.4912
In human alloreactive CD4⁺ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets
Abstract
Although kidney transplantation is the best therapy for end-stage renal disease, rejection remains a concern, and currently available immunosuppressive agents contribute to morbidity and mortality. Thus, novel immunosuppressive drugs are required. Dichloroacetate (DCA) is already used in the treatment of congenital lactic acidosis and characterized by limited toxicity. As DCA inhibits aerobic glycolysis, which is a prerequisite for CD4+ T-cell proliferation and differentiation into effector T-cells, its possible immunosuppressive role in mixed lymphocyte reaction (MLR), a model of alloreactivity, was investigated. Glucose and lactate concentrations were measured in the supernatants, and cell proliferation was assessed immunoenzymatically. CD4+ T‑cells were then isolated from the MLRs and the expression of cleaved caspase‑3, various enzymes involved in glycolysis, and the signature transcription factors of CD4+ T‑cell subsets were evaluated by western blotting. In MLRs, DCA decreased glucose consumption and aerobic glycolysis, while it exerted a negligible effect on cell proliferation. In CD4+ T‑cells, DCA induced apoptosis, and decreased the expression of glucose trasporter‑1, hexokinase II, lactate dehydrogenase‑A and phosphorylated pyruvate dehydrogenase, while it increased total pyruvate dehydrogenase. In addition, DCA increased the expression of transcription factor forkhead box P3, whereas it decreased the expression of T‑box transcription factor TBX21, trans‑acting T-cell-specific transcription factor GATA‑3 and retinoic acid receptor related orphan receptor‑γt. In conclusion, in alloreactive CD4+ T‑cells, DCA inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T‑cell subset. These characteristics render it a promising immunosuppressive agent in the field of transplantation.
Similar articles
-
Dichloroacetate at therapeutic concentration alters glucose metabolism and induces regulatory T-cell differentiation in alloreactive human lymphocytes.J Basic Clin Physiol Pharmacol. 2013;24(4):271-6. doi: 10.1515/jbcpp-2013-0001. J Basic Clin Physiol Pharmacol. 2013. PMID: 23612652
-
Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte reaction affects glucose influx and enzymes involved in aerobic glycolysis and glutaminolysis in alloreactive T-cells.Hum Immunol. 2013 Dec;74(12):1501-9. doi: 10.1016/j.humimm.2013.08.268. Epub 2013 Aug 28. Hum Immunol. 2013. PMID: 23993986
-
Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.Int J Mol Med. 2016 Nov;38(5):1605-1613. doi: 10.3892/ijmm.2016.2750. Epub 2016 Sep 23. Int J Mol Med. 2016. PMID: 27667153
-
Dichloroacetate and cancer: new home for an orphan drug?Biochim Biophys Acta. 2014 Dec;1846(2):617-29. doi: 10.1016/j.bbcan.2014.08.005. Epub 2014 Aug 23. Biochim Biophys Acta. 2014. PMID: 25157892 Review.
-
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.Pharmacol Ther. 2017 Feb;170:166-180. doi: 10.1016/j.pharmthera.2016.10.018. Epub 2016 Oct 19. Pharmacol Ther. 2017. PMID: 27771434 Free PMC article. Review.
Cited by
-
Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging.F1000Res. 2018 Jan 30;7:125. doi: 10.12688/f1000research.11881.1. eCollection 2018. F1000Res. 2018. PMID: 29445452 Free PMC article. Review.
-
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts.Pharmaceuticals (Basel). 2024 Jun 6;17(6):744. doi: 10.3390/ph17060744. Pharmaceuticals (Basel). 2024. PMID: 38931411 Free PMC article. Review.
-
Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma.Front Immunol. 2021 Sep 9;12:680955. doi: 10.3389/fimmu.2021.680955. eCollection 2021. Front Immunol. 2021. PMID: 34566954 Free PMC article. Review.
-
Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease.Front Immunol. 2023 Sep 22;14:1219422. doi: 10.3389/fimmu.2023.1219422. eCollection 2023. Front Immunol. 2023. PMID: 37809060 Free PMC article. Review.
-
The Role of Pyruvate Metabolism in Mitochondrial Quality Control and Inflammation.Mol Cells. 2023 May 31;46(5):259-267. doi: 10.14348/molcells.2023.2128. Epub 2023 Feb 9. Mol Cells. 2023. PMID: 36756776 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials